Nifty crosses 6,000

Auto, metal shares gain

Image
SI Reporter Mumbai
Last Updated : Mar 05 2013 | 9:02 PM IST

Markets continued to trade higher ion the back of the optimism generated by the US fiscal cliff deal. The Sensex has gained 169 points at 19,750. The National Stock Exchange's Nifty-50 index has jumped 53 points to cross the 6K mark and is trading at 6,004.

The US Congress approved a rare tax increase on Tuesday that will hit the nation's wealthiest households in a bipartisan budget deal that stops the world's largest economy from falling into a deep fiscal crisis and recession.

The rupee strengthened by 37 paise to trade at fresh two-week high of Rs 54.31 against the US dollar in early trade today at the Interbank Foreign Exchange on increased dollar selling by exporters and banks amid sustained foreign capital inflows.

Asian markets traded firm. Hong Kong's Hang Seng gained 2% to 23,062, Taiwan's Weighted index rose 1% to 7,784, Singapore's Straits Times was up 1% to 3,200  in morning trades. Equity markets in Japan and mainland China are closed today and tomorrow for public holidays.

On the domestic front, all sectors were trading positive. BSE consumer durables index addecd 1.5% to 7,918. Metal, capital goods and Oil & gas indices have seen buying interest as well and are up 1% each.

Among key Sensex stocks, BHEL is the top gainer - up 2.4% at 238. Metal gainers include Sterlite, Jindal Steel and Hindalco. Maruti Suzuki, HDFC and Cipla are up around 1.5% each. Market heavyweight  -Reliance is up 1.5% at Rs 854.

Select shares have slipped into the negative zone. Mahindra & Mahindra is down 0.6% at Rs 935. Wipro and HUL are marginally in red.

Bajaj Auto has moved higher by 2% at Rs 2,177 after the company said its total sales in December increased 13% year-on-year to 343,946 units, due to higher demand for motorcycles and rise in exports. This is its highest ever December sales figure.

Glenmark Pharmaceuticals is trading higher by 1.4% at Rs 546, extending its Tuesday’s 2.2% gain after the company announced the USFDA approval to Salix Pharmaceuticals for marketing anti-diarrheal drug Crofelemer.

The market breadth is strong as 1686 stocks have advanced compared to 833 stocks which declined on BSE.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 02 2013 | 11:44 AM IST

Next Story